BOSTON (AP) — A member of the family that owns OxyContin maker Purdue Pharma told people at the prescription opioid painkiller’s launch party in the 1990s that it would be “followed by a blizzard of prescriptions that will bury the competition,” according to court documents filed Tuesday.
The details were made public in a case brought by Massachusetts Attorney General Maura Healey that accuses Purdue Pharma, its executives and members of the Sackler family of deceiving patients and doctors about the risks of opioids and pushing prescribers to keep patients on the drug longer. The documents provide information about former Purdue Pharma President Richard Sackler’s role in overseeing sales of OxyContin that hasn’t been public before.
The drug and the closely held Connecticut company that sells it are at the center of a lawsuit in Massachusetts and hundreds of others across the country in which government entities are trying to find the drug industry responsible for an opioid crisis that killed 72,000 Americans in 2017. The Massachusetts litigation is separate from some 1,500 federal lawsuits filed by governments being overseen by a judge in Cleveland.
But the company documents at the heart of the Massachusetts allegations are also part of the evidence exchanged in those cases. While the Massachusetts filing describes their contents, the documents themselves have not been made public, at the company’s request.
Members of the multi-billionaire philanthropic Sackler family that owns the maker of prescription painkiller OxyContin are facing mass litigation and likely criminal investigation over the opioids crisis still ravaging America. Some of the Sacklers wholly own Connecticut-based Purdue Pharma, the company that created and sells the legal narcotic OxyContin, a drug at the center of the opioid epidemic that now kills almost 200 people a day across the US.
A member of the family that owns Purdue Pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication OxyContin — has been awarded a patent for a treatment for opioid use disorder.
The past two years have been a time of reckoning for pharmaceutical manufacturers over their role in promoting opioid drugs that have fed a national epidemic... But as public attention increases, the marketing tide may finally be retreating, a new ProPublica analysis shows. Pharmaceutical company payments to physicians related to opioid drugs decreased significantly in 2016 from the year before.
Purdue Pharma left almost nothing to chance in its whirlwind marketing of its new painkiller OxyContin. From 1996 to 2002, Purdue pursued nearly every avenue in the drug supply and prescription sales chain — a strategy now cast as reckless and illegal in more than 1,500 federal civil lawsuits from communities in Florida to Wisconsin to California that allege the drug has fueled a national epidemic of addiction.
Members of the Sackler family, who’ve made billions pushing their deadly OxyContin drug on the masses are arguably responsible for more deaths than any Mexican drug cartel. Instead of being hunted down at their plush mansions by DEA agents, they are rubbing elbows with members of Congress. Now, however, for the first time, the family is being targeted by a landmark lawsuit for the damages they knowingly caused with their products.
Our IP Address: